Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02544750
Recruitment Status : Enrolling by invitation
First Posted : September 9, 2015
Last Update Posted : October 1, 2018
Sponsor:
Information provided by (Responsible Party):
GW Research Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : February 2022
  Estimated Study Completion Date : February 2022